ADVFN Logo ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Dati di Mercato
Notizie
Utensili
Mercato
Scoprire

Caratteristiche principali

Follow Feed

Connettiti con trader e investitori nella nostra comunità Follow Feed.

Flusso di Opzioni

Esplora i dati completi sulle opzioni e utilizza filtri avanzati con Options Flow.

Monitor

Organizza e monitora la tua watchlist di azioni e attività con Monitor.
Accedi/Registrati Premium IconPremium Help Menu
Ftse Mib
39.142,84
-1,43%
DAX
22.962,85
-1,45%
S&P 500
5.675,29
1,08%
NASDAQ
17.750,79
0,00%
Bitcoin
85.379,44
-1,74%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati
  1. Home
  2. Investire
  3. Azioni
  4. U.S.A.
  5. NASDAQ
  6. Pacira BioSciences Inc (PCRX)

  7. Pacira BioSciences Inc (PCRX) Notizie

PCRX

Pacira BioSciences (PCRX)

Pacira BioSciences Inc
Da:
Ordina per:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PCRX
DataOraFonteTitoloSimboloCompagnia
14/03/202522:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
14/03/202522:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PCRXPacira BioSciences Inc
14/03/202521:06Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:PCRXPacira BioSciences Inc
14/03/202521:05GlobeNewswire Inc.Pacira BioSciences Confirms Receipt of Director Nominations from DOMA PerpetualNASDAQ:PCRXPacira BioSciences Inc
14/03/202513:25PR Newswire (US)DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciencesNASDAQ:PCRXPacira BioSciences Inc
13/03/202510:45PR Newswire (US)Pacira BioSciences, Inc. Class Action: The Gross Law Firm Reminds Pacira Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRXNASDAQ:PCRXPacira BioSciences Inc
10/03/202510:45PR Newswire (US)Shareholders that lost money on Pacira BioSciences, Inc.(PCRX) should contact The Gross Law Firm about pending Class Action - PCRXNASDAQ:PCRXPacira BioSciences Inc
06/03/202518:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCRXPacira BioSciences Inc
06/03/202514:00GlobeNewswire Inc.Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PCRXPacira BioSciences Inc
06/03/202511:45PR Newswire (US)The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc.(PCRX) of a Class Action Lawsuit and an Upcoming DeadlineNASDAQ:PCRXPacira BioSciences Inc
03/03/202511:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira Lawsuit - PCRXNASDAQ:PCRXPacira BioSciences Inc
27/02/202523:07Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PCRXPacira BioSciences Inc
27/02/202522:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PCRXPacira BioSciences Inc
27/02/202522:05GlobeNewswire Inc.Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial ResultsNASDAQ:PCRXPacira BioSciences Inc
27/02/202522:00GlobeNewswire Inc.Pacira BioSciences Acquires Remaining Equity Stake of GQ BioNASDAQ:PCRXPacira BioSciences Inc
26/02/202514:00GlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in MarchNASDAQ:PCRXPacira BioSciences Inc
20/02/202514:00GlobeNewswire Inc.Pacira to Report 2024 Financial Results on Thursday February 27, 2025NASDAQ:PCRXPacira BioSciences Inc
20/02/202511:45PR Newswire (US)Investors in Pacira BioSciences, Inc. Should Contact The Gross Law Firm Before March 14, 2025 to Discuss Your Rights - PCRXNASDAQ:PCRXPacira BioSciences Inc
13/02/202511:45PR Newswire (US)The Gross Law Firm Reminds Pacira BioSciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRXNASDAQ:PCRXPacira BioSciences Inc
10/02/202511:45PR Newswire (US)Pacira BioSciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 14, 2025 to Discuss Your Rights - PCRXNASDAQ:PCRXPacira BioSciences Inc
05/02/202500:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
03/02/202511:45PR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Pacira BioSciences, Inc.(PCRX) ShareholdersNASDAQ:PCRXPacira BioSciences Inc
30/01/202514:00GlobeNewswire Inc.Pacira Announces Updates to Board of DirectorsNASDAQ:PCRXPacira BioSciences Inc
30/01/202511:45PR Newswire (US)The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc. (PCRX) of a Class Action Lawsuit and an Upcoming DeadlineNASDAQ:PCRXPacira BioSciences Inc
28/01/202523:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
23/01/202511:45PR Newswire (US)Investors who lost money on Pacira BioSciences, Inc.(PCRX) should contact The Gross Law Firm about pending Class Action - PCRXNASDAQ:PCRXPacira BioSciences Inc
21/01/202514:00GlobeNewswire Inc.Pacira BioSciences Strengthens Executive Leadership Team with Two Key AppointmentsNASDAQ:PCRXPacira BioSciences Inc
20/01/202511:45PR Newswire (US)Pacira BioSciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - PCRXNASDAQ:PCRXPacira BioSciences Inc
16/01/202511:45PR Newswire (US)Pacira BioSciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before March 14, 2025 to Discuss Your Rights - PCRXNASDAQ:PCRXPacira BioSciences Inc
10/01/202514:00GlobeNewswire Inc.Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical OrganizationNASDAQ:PCRXPacira BioSciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PCRX

La tua Cronologia

EU
9468S
9468S
BOV
HSLG11
FII HSI Logistica
GATE
RPKUSDT
RepubliK
BOV
CSUD3T
CSU Digital
BOV
NEWU11
Newport Renda Urbana Fun...
BOV
BBIM11
BB Recebiveis Imobiliari...
BOV
QUAL3R
QUALICORP ON
EU
VDPAN
Ville de Paris VPARIS2.4...
BOV
FIQE3R
Unifique Telecomunicacoes ON
BOV
LAND3M
Terra Santa Propriedades... ON
UNSW
NUXETH
NUX Peanut.trade
BOV
B1BT34
Truist Financial
BOV
CSMG3T
COPASA
BOV
VIVA3R
VIVARA ON
COIN
QKCBTC
QuarkChain
BOV
BGIP3R
BANESE ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Italia
Azienda
Attività
Popular
Ottieni l'app
App Store
Google Play

Assistenza: help@advfn.com

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

© 2025 ADVFN PLC - Tutti i diritti riservati

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci